Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

14. Juli 2026 10:08 ET | Quelle: Research and Markets

Amivantamab Lazertinib Forecast to Lead US EGFR NSCLC Therapy Revenue by 2036 as Post-TAGRISSO Competition Intensifies

Dublin, July 14, 2026 (GLOBE NEWSWIRE) -- The "Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer (EGFR-NSCLC) - Market Insight, Epidemiology, and Market Forecast - 2036" has been added to ...
14. Mai 2026 07:45 ET | Quelle: Research and Markets

C-Met-Targeted Immunotherapies Pipeline Competitive Intelligence Report 2026: CCR8-targeted R&D Programs and Profile of CCR8-targeted Immunotherapies by Drug Modality

Dublin, May 14, 2026 (GLOBE NEWSWIRE) -- The "Pipeline of c-Met-Targeted Immunotherapies" report has been added to ResearchAndMarkets.com's offering.This competitive intelligence report about...
21. April 2026 05:56 ET | Quelle: Research and Markets

EGFR Non-Small Cell Lung Cancer Market Report 2026: Revenue to Exceed $10 Billion in 2026, Growing by $730 Million YOY

Dublin, April 21, 2026 (GLOBE NEWSWIRE) -- The "EGFR Non-Small Cell Lung Cancer Market Report 2026" has been added to ResearchAndMarkets.com's offering. The report offers comprehensive insights...
13. April 2026 04:32 ET | Quelle: Research and Markets

BRAF Mutated Non-small Cell Lung Cancer (NSCLC) Market Insight, Epidemiology, and Market Forecast Report 2022-2026 & 2026-2036 Featuring Novartis, Genentech, Fore Biotherapeutic, and C4 Therapeutics

Dublin, April 13, 2026 (GLOBE NEWSWIRE) -- The "BRAF Mutated Non-small Cell Lung Cancer (NSCLC) - Market Insight, Epidemiology, and Market Forecast - 2036" has been added to ...
02. April 2026 11:49 ET | Quelle: Research and Markets

Programmed Death (PD)-1 Non-Small Cell Lung Cancer Market Intelligence Report 2026-2030: Industry Growth Driven by Personalized Treatment Adoption

Dublin, April 02, 2026 (GLOBE NEWSWIRE) -- The "Programmed Death (PD)-1 Non-Small Cell Lung Cancer Market Report 2026" has been added to ResearchAndMarkets.com's offering. The report offers a...
02. April 2026 10:50 ET | Quelle: Research and Markets

Next-Gen Oncology Devices and Solutions Market to Double by 2030, Reaching Over $38 Billion

Dublin, April 02, 2026 (GLOBE NEWSWIRE) -- The "Next-Generation Oncology Devices and Solutions Market Report 2026" has been added to ResearchAndMarkets.com's offering. The next-generation...
02. April 2026 10:47 ET | Quelle: Research and Markets

Metastatic Lung Adenocarcinoma Treatment Market Outlook Report 2026-2030: Targeted Therapies Fuel Growth, with Revenues Reaching $5 Billion by 2030

Dublin, April 02, 2026 (GLOBE NEWSWIRE) -- The "Metastatic Lung Adenocarcinoma Treatment Market Report 2026" has been added to ResearchAndMarkets.com's offering. The metastatic lung...
30. März 2026 05:05 ET | Quelle: Research and Markets

Non-Small Cell Lung Cancer (NSCLC) Global Market Trends and Regional Growth Insights 2026-2030: Rapid Adoption of Targeted Therapies and Immunotherapy Fuels Market Expansion, Reaching $70.8 Billion by 2030

Dublin, March 30, 2026 (GLOBE NEWSWIRE) -- The "Non-Small Cell Lung Cancer (NSCLC) Market Report 2026" has been added to ResearchAndMarkets.com's offering. The non-small cell lung cancer...
30. März 2026 04:28 ET | Quelle: Research and Markets

Cancer Clinical Decision Tools Market to Grow by $280 Million During 2026-2030: Key Growth Areas & Competitive Strategies Identified

Dublin, March 30, 2026 (GLOBE NEWSWIRE) -- The "Cancer Clinical Decision Tools Market Report 2026" has been added to ResearchAndMarkets.com's offering. The global cancer clinical decision tools...
14. Januar 2026 08:38 ET | Quelle: Research and Markets

$105+ Bn Non-Small Cell Lung Cancer (NSCLC) Global Market Trends, Strategies, and Opportunities, 2019-2024, 2024-2029F, 2034F

Dublin, Jan. 14, 2026 (GLOBE NEWSWIRE) -- The "Non-Small Cell Lung Cancer (NSCLC) Global Market Opportunities and Strategies to 2034" has been added to ResearchAndMarkets.com's offering. The...

Nächste Seite